Weight Loss Achieved by Overweight and Obese Subjects Entering the LipotrimÃ‚Â® Weight Loss Programme Monitored by Pharmacists in England
The objective of this report was to assess the results of a weight-loss programme managed by pharmacistsÃ‚Â since obesity and type-2 diabetes are serious problems in the UK. We evaluated the service provided by pharmacistsÃ‚Â in the UK to manage and continuously monitor a very low energy diet (VLED) program based on LipotrimÃ‚Â® forÃ‚Â overweight and obese people who wished to lose weight. Between 2008 to 2013, 57 (~3%) of 2000+ pharmaciesÃ‚Â offering the service elected to utilise online tracker software instead of paper records. Extrapolation of the subject
numbers from this subset to the full population presenting to participating pharmacies for weight managementÃ‚Â yields an estimate of more than 300,000 people. 8724 overweight people voluntarily enquired about the weightÃ‚Â loss program at the 57 pharmacies. Approximately 50% of these people completed at least two full weeks andÃ‚Â their information was analysed in this report. Of the 50% who completed two weeks, 30% (1077 women, 241 men),Ã‚Â displayed a period of linear decline in weight and at a mean duration of ~60 days, mean weight loss in women was
12 kg (-12.6% initial weight) and in men was 16.5 kg (-13.8%). The remaining 70% (2487 women, 540 men) lostÃ‚Â 8.0 and 11.5 kg over 104 and 122 days respectively. In conclusion, weight losses in those people who persisted inÃ‚Â the program will have a public health benefit and potentially reduce their risk of co-morbidities such as diabetes.Ã‚Â Pharmacists in the UK are ideally placed to provide and monitor weight loss programs for overweight people.